KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hims & Hers Health (HIMS) Gains from Investment Securities (2020 - 2025)

Historic Gains from Investment Securities for Hims & Hers Health (HIMS) over the last 6 years, with Q3 2025 value amounting to $69.4 million.

  • Hims & Hers Health's Gains from Investment Securities rose 54172.91% to $69.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $152.2 million, marking a year-over-year increase of 31045.54%. This contributed to the annual value of $52.5 million for FY2024, which is 27245.32% up from last year.
  • Hims & Hers Health's Gains from Investment Securities amounted to $69.4 million in Q3 2025, which was up 54172.91% from $11.0 million recorded in Q2 2025.
  • Over the past 5 years, Hims & Hers Health's Gains from Investment Securities peaked at $69.4 million during Q3 2025, and registered a low of -$758000.0 during Q4 2021.
  • Moreover, its 5-year median value for Gains from Investment Securities was $3.8 million (2023), whereas its average is $11.0 million.
  • Over the last 5 years, Hims & Hers Health's Gains from Investment Securities had its largest YoY gain of 532272.73% in 2021, and its largest YoY loss of 20557.1% in 2021.
  • Over the past 5 years, Hims & Hers Health's Gains from Investment Securities (Quarter) stood at -$758000.0 in 2021, then skyrocketed by 302.77% to $1.5 million in 2022, then surged by 159.92% to $4.0 million in 2023, then soared by 385.73% to $19.4 million in 2024, then skyrocketed by 257.66% to $69.4 million in 2025.
  • Its Gains from Investment Securities stands at $69.4 million for Q3 2025, versus $11.0 million for Q2 2025 and $52.5 million for Q1 2025.